| Utilization and outcomes of measuring fractional flow reserve in patients with stable ischemic heart disease RV Parikh, G Liu, ME Plomondon, TSG Sehested, MA Hlatky, SW Waldo, ... Journal of the American College of Cardiology 75 (4), 409-419, 2020 | 124 | 2020 |
| Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction TSG Sehested, N Carlson, PW Hansen, TA Gerds, MG Charlot, ... European Heart Journal 40 (24), 1963-1970, 2019 | 84 | 2019 |
| Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction TSG Sehested, TA Gerds, EL Fosbøl, PW Hansen, MG Charlot, N Carlson, ... Journal of internal medicine 283 (3), 268-281, 2018 | 79 | 2018 |
| Cost-effectiveness of canakinumab for prevention of recurrent cardiovascular events TSG Sehested, J Bjerre, S Ku, A Chang, A Jahansouz, DK Owens, ... JAMA cardiology 4 (2), 128-135, 2019 | 67 | 2019 |
| Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study E Seven, LLN Husemoen, TSG Sehested, H Ibsen, K Wachtell, ... PloS one 10 (6), e0128987, 2015 | 64 | 2015 |
| Measures of overweight and obesity and risk of cardiovascular disease: a population-based study TSG Sehested, TW Hansen, MH Olsen, SZ Abildstrøm, S Rasmussen, ... European Journal of Preventive Cardiology 17 (4), 486-490, 2010 | 50 | 2010 |
| Does estimated pulse wave velocity add prognostic information? MORGAM Prospective Cohort Project JKK Vishram-Nielsen, S Laurent, PM Nilsson, A Linneberg, ... Hypertension 75 (6), 1420-1428, 2020 | 49 | 2020 |
| Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012–a nationwide study S Kamil, TSG Sehested, N Carlson, K Houlind, JF Lassen, C N. Bang, ... BMC Cardiovascular Disorders 19, 1-9, 2019 | 39 | 2019 |
| Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial AMD Kristensen, A Bovin, AD Zwisler, C Cerquira, C Torp-Pedersen, ... Trials 21, 1-11, 2020 | 29 | 2020 |
| Identifying drug–drug interactions by data mining: a pilot study of warfarin-associated drug interactions PW Hansen, L Clemmensen, TSG Sehested, EL Fosbøl, C Torp-Pedersen, ... Circulation: Cardiovascular Quality and Outcomes 9 (6), 621-628, 2016 | 23 | 2016 |
| Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011 PW Hansen, TSG Sehested, EL Fosbøl, C Torp-Pedersen, L Køber, ... PLoS One 13 (3), e0194295, 2018 | 19 | 2018 |
| Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study M El-Chouli, A Meddis, DM Christensen, TA Gerds, T Sehested, ... European heart journal 44 (9), 741-748, 2023 | 17 | 2023 |
| Age-and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021 DM Christensen, JE Strange, M Phelps, AM Schjerning, TSG Sehested, ... Atherosclerosis 346, 63-67, 2022 | 17 | 2022 |
| Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study DM Christensen, AM Schjerning, L Smedegaard, MG Charlot, PB Ravn, ... European Heart Journal 44 (6), 488-498, 2023 | 14 | 2023 |
| Risk and trajectory of premature ischaemic cardiovascular disease in women with a history of pre-eclampsia: a nationwide register-based study S Hallum, S Basit, M Kamper-Jørgensen, TSG Sehested, HA Boyd European Journal of Preventive Cardiology 30 (6), 506-516, 2023 | 12 | 2023 |
| Proton pump inhibitor use increases the associated risk of first-time ischemic stroke. A nationwide cohort study TS Sehested, EL Fosbøl, PW Hansen, MG Charlot, C Torp-Pedersen, ... Circulation 134 (suppl_1), A18462-A18462, 2016 | 10 | 2016 |
| Unstable angina as a component of primary composite endpoints in clinical cardiovascular trials: pros and cons AMD Kristensen, M Pareek, KH Kragholm, TSG Sehested, MH Olsen, ... Cardiology 147 (3), 235-247, 2022 | 9 | 2022 |
| Impact of male-origin microchimerism on cardiovascular disease in women: A prospective cohort study S Hallum, TA Gerds, TSG Sehested, MA Jakobsen, A Tjønneland, ... American Journal of Epidemiology 190 (5), 853-863, 2021 | 9 | 2021 |
| Verordnungspraxis und Risiken von Protonenpumpenblockern–Fiktion und Fakten H Koop Zeitschrift für Gastroenterologie 56 (03), 264-274, 2018 | 9 | 2018 |
| Trends in use of cardioprotective medication in peripheral artery disease: a nationwide study S Kamil, TSG Sehested, K Houlind, JF Lassen, GH Gislason, ... Journal of the American Heart Association 10 (15), e020333, 2021 | 5 | 2021 |
